- Research works
- 23 ▲ 94% vs 2018-21
- Citations
- 736 32.7 per fractional work
- Top-10% rate
- 0.0% all institutions 10.0%
- Open access
- 6% world 40%
- International
- 8% world 18%
Not ranked overall: ScinoPharm Taiwan (Taiwan) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does ScinoPharm Taiwan (Taiwan) work in?
In all years, 61% of research at ScinoPharm Taiwan (Taiwan) is in Physical Sciences, 20% in Life Sciences. Its largest fields are Chemistry (35%), Biochemistry, Genetics and Molecular Biology (18%), Medicine (18%). It does 1.4× the world's share of Physical Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 11 fields, with their numbers
- Physical Sciences1461.0%
- Chemistry834.6%
- Engineering311.3%
- Materials Science27.3%
- Environmental Science13.3%
- Physics and Astronomy12.3%
- Energy02.2%
- Life Sciences520.4%
- Health Sciences418.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at ScinoPharm Taiwan (Taiwan)?
Ranked on the quality score, Julian P. Henschke lead among researchers whose main affiliation is ScinoPharm Taiwan (Taiwan).
- 1
Julian P. Henschke
Taiwan · #3,297,765 worldwide 921 citations · 40 works
Which keywords describe research at ScinoPharm Taiwan (Taiwan)?
By fractional works in all years, weighted toward what it does more of than the world: Transition Metal Catalysis, Enantioselective Reactions, Organocatalysis, C-C Bond Formation, Asymmetric Synthesis, Chiral Catalysts, Spirooxindoles and Anti-inflammatory.
- Chiral Ligands
- Recycling
- Nanoparticles
- Glycosidase Inhibitors
- Asymmetric Catalysis
- Anti-inflammatory
- Chiral Catalysts
- Asymmetric Synthesis
- Enantioselective Reactions
- Transition Metal Catalysis
- Organocatalysis
- C-C Bond Formation
- Spirooxindoles
- Antioxidant
- Enantioselective Synthesis
- Metal-Catalyzed Reactions
- Oligosaccharide Synthesis
- Cancer
- Transition Metal Complexes
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Transition Metal Catalysis2▲ 75×3 topics
- Enantioselective Reactions2▲ 110×2 topics
- Organocatalysis2▲ 123×3 topics
- Asymmetric Synthesis2▲ 54×4 topics
- C-C Bond Formation2▲ 85×2 topics
- Chiral Catalysts1▲ 124×1 topic
- Spirooxindoles1▲ 124×1 topic
- Anti-inflammatory1▲ 21×5 topics
- Antioxidant1▲ 8.7×5 topics
- Asymmetric Catalysis1▲ 85×2 topics
- Enantioselective Synthesis1▲ 33×3 topics
- Glycosidase Inhibitors1▲ 101×1 topic
- Metal-Catalyzed Reactions1▲ 58×2 topics
- Nanoparticles1▲ 4.0×6 topics
- Oligosaccharide Synthesis1▲ 101×1 topic
- Recycling1▲ 21×3 topics
- Cancer1▲ 3.6×6 topics
- Chiral Ligands1▲ 90×2 topics
- Transition Metal Complexes1▲ 42×2 topics
Which research topics does ScinoPharm Taiwan (Taiwan) publish most on?
By volume in 2022-now: Mass Spectrometry Techniques and Applications, RNA and protein synthesis mechanisms and Chemical Synthesis and Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has ScinoPharm Taiwan (Taiwan)'s research output changed?
Output in 2022-2025 was 94% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is ScinoPharm Taiwan (Taiwan) as a percentage of every work published that year, 0.0000038% in 2019.
Fractional works of ScinoPharm Taiwan (Taiwan) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Tainan City
- National Cheng Kung University
- Southern Taiwan University of Science and Technology
- Chi Mei Medical Center
- Kun Shan University
- University of Kang Ning
- National University of Tainan
- Chia Nan University of Pharmacy and Science
- Chang Jung Christian University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about ScinoPharm Taiwan (Taiwan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.